Skip to main content
. 2021 Mar 26;41(5):1110–1121. doi: 10.1038/s41372-021-01044-3

Table 2.

Transfusion frequency in three subtypes of necrotizing enterocolitis.

Combined cohort (N = 336) Medical non-fulminant NEC (N = 138) Surgical non-fulminant NEC (N = 163) Fulminant NEC (N = 35) P1 Ful vs. SNF P2 Ful vs. MNF P3 SNF vs. MNF
Platelet transfusion before NEC n = 226 n = 56 n = 152 n = 18
 Number of platelet transfusion, n (%) 0.319 0.337 0.892
     0 192 (85.0%) 48 (85.7%) 130 (85.5%) 14 (77.8%)
     1 17 (7.52%) 5 (8.93%) 11 (7.24%) 1 (5.56%)
     2 8 (3.54%) 1 (1.79%) 6 (3.95%) 1 (5.56%)
     3+ 9 (3.98%) 2 (3.57%) 5 (3.29%) 2 (11.1%)
Platelet transfusion after 48 h n = 226 n = 53 n = 154 n = 19
 Number of platelet transfusion, n (%) 0.373 0.002 <0.001
     0 149 (65.9%) 48 (90.6%) 90 (58.4%) 11 (57.9%)
     1 46 (20.4%) 3 (5.66%) 36 (23.4%) 7 (36.8%)
     2 17 (7.52%) 1 (1.89%) 16 (10.4%) 0 (0.00%)
     3+ 14 (6.19%) 1 (1.89%) 12 (7.79%) 1 (5.26%)
RBC transfusion before NEC n = 296 n = 122 n = 143 n = 31
 Number of RBC transfusion, n (%) 0.392 0.335 0.246
     0 155 (52.4%) 67 (54.9%) 71 (49.7%) 17 (54.8%)
     1 29 (9.80%) 12 (9.84%) 12 (8.39%) 5 (16.1%)
     2 35 (11.8%) 9 (7.38%) 22 (15.4%) 4 (12.9%)
     3+ 77 (26.0%) 34 (27.9%) 38 (26.6%) 5 (16.1%)
RBC transfusion after 48 h NEC n = 281 n = 113 n = 137 n = 31
 Number of RBC transfusion, n (%) 0.574 <0.001 <0.001
     0 117 (41.6%) 79 (69.9%) 31 (22.6%) 7 (22.6%)
     1 91 (32.4%) 29 (25.7%) 48 (35.0%) 14 (45.2%)
     2 40 (14.2%) 4 (3.54%) 32 (23.4%) 4 (12.9%)
     3+ 33 (11.7%) 1 (0.88%) 26 (19.0%) 6 (19.4%)

Data represented as n (%); differences in categorical measures tested using the Chi-squared test or Fisher’s exact test; P1 = Fulminant vs. surgical non-fulminant (SNF), P2 = fulminant (ful) vs. medical non-fulminant (MNF), P3 = MNF vs. SNF, p < 0.05 significant.

Statistically significant p < 0.05 values are in bold.

NEC necrotizing enterocolitis, RBC red blood cell.